Australia markets closed

Control Bionics Limited (CBL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.04600.0000 (0.00%)
At close: 04:10PM AEDT

Control Bionics Limited

697 Bourke Road
Level 5, Suite 5.01
Camberwell, VIC 3124
Australia
61 3 9897 3576
https://www.controlbionics.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Jeremy E. SteeleCEO, MD & Director363.72kN/AN/A
Mr. Peter Shann FordFounder & Non-Executive Director215.75kN/AN/A
Mr. Dominik KuceraInterim Chief Financial Officer373.96kN/AN/A
Mr. James SchoreyChief Technology OfficerN/AN/AN/A
Ms. Meagan KoenemanSales DirectorN/AN/AN/A
Mr. Brett Thomas Crowley B.Com., BCom, C.A., CA, DipLawCompany SecretaryN/AN/A1957
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia and North America. The company offers NeuroNode Trilogy and NeuroNode3 systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that can be used with a Windows display device; NeuroNode, a wireless wearable sensor that gives the user the ability to access their technology by bioelectric signals or spatial movements; Uno Touch, a speech generating device; NeuroNode Duo, a wireless sensor; and Eye gaze Duo that allows the user to control a computer mouse with their eyes. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Camberwell, Australia.

Corporate governance

Control Bionics Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.